Beruflich Dokumente
Kultur Dokumente
39 (2006) 723–740
Revision Mastoidectomy
Joseph B. Nadol Jr, MDa,b
a
Department of Otology and Laryngology, Harvard Medical School, Boston, MA, USA
b
Department of Otolaryngology, Massachusetts Eye and Ear Infirmary,
243 Charles St., Boston, MA 02114, USA
The first three priorities in surgery for chronic otitis media are (1) the
elimination of progressive disease to produce a safe and dry ear, (2) modi-
fication of the anatomy of the tympanomastoid compartment to prevent re-
current disease, and (3) reconstruction of the hearing mechanism. The
indications for revision following mastoidectomy for chronic otitis media
thus involve failure to achieve any of these goals, including recurrent choles-
teatoma, recurrent suppuration, recurrent perforation, or recurrent or resid-
ual conductive hearing loss. The focus of this article is the management of
recurrent cholesteatoma or suppuration; that is, failure to achieve either
of the first two priorities.
The published failure rates for primary mastoidectomy for chronic
suppurative otitis media vary widely, ranging from 3% to 26%, or more
[1–12]. The factors responsible for surgical failure are multiple, and include
the subcategory of disease, the anatomic consequences of primary surgery,
or a combination of the original disease process and the surgical approach
selected. For example, chronic otitis media with cholesteatoma treated with
canal wall up mastoidectomy has been recognized as having a high rate of
residual and recurrent cholesteatoma, in the range of 29% or higher
[4,7,11], whereas other investigators [13] have suggested that chronic otitis
media without cholesteatoma, but with granulation tissue, is more difficult
to control over the long-term than cholesteatoma, perhaps because of
more widespread disease.
Given the wide spectrum of disease included in the term ‘‘chronic otitis
media,’’ and the number of surgical procedures that may be used to address
this disorder, the development of a successful strategy for revision mastoid-
ectomy requires a clear and logical nomenclature, both for diagnostic
0030-6665/06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.otc.2006.05.003 oto.theclinics.com
724 NADOL
Sclerosing processes
Fibrocystic sclerosis
As a result of chronic suppuration and granulation tissue, fibrous tissue
may be deposited in the submucosal plane, causing progressive sequestra-
tion and loculation of previously pneumatized spaces of the middle ear
and mastoid (Fig. 1). This process may lead to clinically identifiable entities,
such as ‘‘aditus block’’ [14,15]. Fibrocystic sclerosis may also exacerbate
dysfunction of the eustachian tube and limit the potential for reconstructive
procedures for hearing, when the process involves either the oval or round
window areas. The presence of fibrocystic sclerosis often is interpreted on
radiographic imaging as ‘‘soft tissue opacification’’ of the middle ear or
mastoid.
Fibro-osseous sclerosis
The reparative process in chronic active otitis media also includes the de-
position of new bone, which, like fibrocystic sclerosis, may result in obstruc-
tion and loculation of disease (Fig. 2). Often, the presence of fibro-osseous
sclerosis is detected on radiographic imaging of the temporal bone and is
identified by the radiologist as a ‘‘poorly pneumatized’’ or ‘‘sclerotic’’ mas-
toid. Fibro-osseous sclerosis may also interfere with identification of critical
landmarks in chronic ear surgery and may impede complete exenteration of
infected mastoid cells.
Fig. 1. Fibrocystic sclerosis of the middle ear and mastoid in the left ear of a patient with
chronic otitis media. In the middle ear, the fibrocystic sclerosis surrounds the stapes superstruc-
ture. C, cochlea; CMT, mastoid; EAC, external auditory canal; FCS, fibrocystic sclerosis; M,
manubrium; ME, middle ear ; VII, facial nerve; S, stapes superstructure.
REVISION MASTOIDECTOMY 727
Fig. 2. Fibro-osseous sclerosis. Fibrous tissue (F) and new bone (NB) fill much of the central
mastoid track (CMT) and middle ear (ME) in the left ear of a patient with chronic otitis media.
Osteoresorptive processes
Rarifying osteitis
Osteoclastic resorption of bone within the mastoid, otic capsule, or ossi-
cles may occur, even in the absence of osteomyelitis, and may accompany
chronic active otitis media with or without cholesteatoma (Fig. 3). It may
lead to either limited or broad exposure of the dura of the middle or poste-
rior cranial fossa; dehiscences of the otic capsule, resulting in labyrinthine
fistulas (Fig. 4); or extensive exposure of the facial nerve, usually in the hor-
izontal and first portion of the descending segments. A hint as to the pres-
ence of rarifying osteitis can be detected on radiologic imaging of the
temporal bone, and is described by radiologists in various terms, such as
‘‘bony resorption’’ or ‘‘presence of an osteolytic process.’’
The revision surgeon is well served by the use of a diagnostic algorithm
for self-categorization of the recurrent disease, and the development of a ra-
tional medical and surgical approach to management. Key elements include
clinical evaluation, bacteriology, radiologic imaging, and analysis of previ-
ous surgical failure.
Clinical evaluation
Clinical evaluation includes a thorough and specific otologic history and
otoscopic examination. The otologist may wish to develop a checklist simi-
lar to the process used by an airline pilot in preparation for flight. Elements
of the checklist and key elements of both history and examination are pro-
vided in Box 3. Pertinent elements of the history of chronic otitis media in-
clude characterization and onset of the original disease process; details, as
best can be determined, of prior otologic surgery; and a detailed description
of the onset and characterization of recurrent symptoms. For example, if
there is otorrhea, is it constant or intermittent? Is there pain or hearing
loss, or are there facial nerve or other cranial neuropathies or vestibular
728 NADOL
Fig. 3. Rarifying osteitis. As a consequence of chronic otitis media, the otic capsule (OC) was
partially resorbed.
Fig. 4. Rarifying osteitis of the vestibular labyrinth. In this left ear, with chronic otitis media
and cholesteatoma (CH), there is partial resorption (R) of the bone overlying the lateral semi-
circular canal (LSC).
REVISION MASTOIDECTOMY 729
II. Bacteriology
III. Radiologic imaging
IV. Analysis of reasons for previous surgical failure
ridge, evaluation of residual mastoid cells, and access for otologic hygiene in
such areas as the sinodural angle or mastoid tip.
In cases in which otorrhea is an important element of the disease process,
culture and sensitivity of pathogens may play a significant role. For exam-
ple, chronic suppurative otitis media, particularly following canal wall
down procedures, may include several simultaneous pathogens, such as an-
aerobic organisms [16,17], and commonly used otologic topical antibiotics,
in general, have poor anaerobic coverage. In the absence of cholesteatoma,
medical management of chronic suppurative otitis media may be considered,
at least initially [18].
Radiologic imaging
Radiologic imaging, principally CT, MRI, and magnetic resonance angi-
ography, may provide important information to guide the revision surgery.
For example, CT scanning may demonstrate the location of unexenterated
and sequestrated cells in the hypotympanum (Fig. 5) or the presence of an
unanticipated disease beyond the usual confines of the mastoid (Figs. 6
and 7), and may aid in the analysis of the reasons for previous surgical
failure.
The information achieved by clinical evaluation, bacteriology, and radio-
logic imaging is integrated to form an educated opinion concerning the
730 NADOL
Fig. 5. Hypotympanic involvement by chronic otitis media of the left ear. (A) The CT scan
demonstrated erosion of the hypotympanic cell system (short arrow). A resultant cochlear fistula
(long arrow) caused profound sensorineural hearing loss. (B) The MR scan with gadolinium en-
hancement demonstrated enhancing granulation tissue in the hypotympanum (arrow). (From
Nadol JB, McKenna MJ. Surgery of the ear and temporal bone. 2nd edition. Philadelphia: Lip-
pincott, Williams and Wilkins; 2005; with permission.)
reasons for previous mastoid surgery failure; this will allow establishment of
a rational treatment algorithm. Examples of common scenarios and analysis
of previous surgical failure are shown in Box 4. It is useful to separate sur-
gical failures into early failures, which in large part represent residual dis-
ease, and late failures, which may imply recurrent disease.
The typical scenarios may differ for early and late failures, based on the
previous surgical approach. Thus, a common cause for surgical failure in
Fig. 6. A cholesteatoma (arrow) is shown in the soft tissue inferior to the left mastoid tip in this
65-year-old man who underwent multiple revision surgical procedures for chronic otitis media
complicated by neck abscesses. A cholesteatoma had broken through the mastoid cortex and
extended to the neck. This component of the cholesteatoma was overlooked in multiple revision
procedures until demonstrated on this CT before the final surgical procedure. (From Nadol JB,
McKenna MJ. Surgery of the ear and temporal bone. 2nd edition. Philadelphia: Lippincott,
Williams and Wilkins; 2005; with permission.)
REVISION MASTOIDECTOMY 731
Fig. 7. Extension of chronic otitis media from the mastoid to the petrous apex in a patient who
underwent multiple revision procedures for chronic otitis media. The CT scan (A) and MRI (B)
demonstrated a large cyst of the petrous apex (arrow) that was in direct continuity with the in-
fected tympanomastoid air cell system by way of the infralabyrinthine (hypotympanic) cells.
This infected cyst served as a reservoir for continued otorrhea for many years. (From Nadol
JB, McKenna MJ. Surgery of the ear and temporal bone. 2nd edition. Philadelphia: Lippincott,
Williams and Wilkins; 2005; with permission.)
Fig. 8. Chronically draining mastoid bowl following a fenestration procedure. This patient un-
derwent a fenestration procedure for otosclerosis at the age of 42 in the left ear and had chronic
intermittent otorrhea until his death at age 63. There was chronic inflammation and ulceration
(U) and fibrocystic sclerosis (FCS) in both the mastoid bowl (MB) and in the middle ear space
(ME).
Surgical exposure
Limited middle ear disease may be managed by transmeatal or endaural
incisions; however, in general, the postauricular incision is best suited for
wide exposure and visualization of the disease process, including unantici-
pated findings. In an effort to prevent surgical injury to structures that
may have been exposed by either the disease process or the previous surgical
procedure, such as the dura of the middle or posterior cranial fossa, lateral
venous sinus, or facial nerve, modification of the usual procedure is indi-
cated. A somewhat longer postauricular incision allows identification of
proper planes, and wider exposure. Beginning the surgical procedure both
superior and posterior to the previous surgical field facilitates proper iden-
tification and avoidance of injury to these structures, and identification of
surgical landmarks.
Generally, adhesions between musculofascial pedicles and bone are di-
vided easily. In contrast, tight adherence between soft tissue and underlying
structures strongly suggests adhesions between the soft tissue pedicle and
underlying dura or other critical structures, such as the facial nerve. Usually,
such adhesions then are cut sharply, rather than avulsed, in an effort to
avoid injury.
Intraoperative monitoring of facial nerve function assists significantly in
identifying the facial nerve in a previously surgically altered field, and pro-
vides an early warning system to identify maneuvers that may injure the
nerve, such as dissection of pedicles from the nerve. In the presence of
granulation tissue, particular attention should be paid to the mastoid tip,
sinodural angle, tegmental cells, and hypotympanum (Fig. 9) [19,20].
Similarly, in chronic active otitis media with cholesteatoma and otorrhea,
REVISION MASTOIDECTOMY 735
Fig. 9. An incomplete mastoidectomy (right ear). The facial ridge (FR) has not been lowered to
the level of the nerve. In addition, there are many residual cells along the tegmen (TEG), in the
sinodural angle (SDA), and in the mastoid tip (MT).
simple removal of the cholesteatoma and otorrhea does not result in cessa-
tion of suppuration caused by sequestration and loculation of disease within
the mastoid cell system.
Canalplasty
Canalplasty (particularly in a tortuous or narrow ear canal), accom-
plished by removing bone from the tympanic segment of the external audi-
tory canal, greatly facilitates access, both intraoperatively and
postoperatively. Widening and straightening the canal also helps to prevent
736 NADOL
Fig. 10. Access to the sinus tympani (ST), which is located medial to the facial nerve (VII) and
to the hypotympanic cells, is facilitated by removal of bone between the facial nerve (VII),
round window (RW), and carotid canal (CC), as shown in the triangle. (From Nadol JB,
McKenna MJ. Surgery of the ear and temporal bone. 2nd edition. Philadelphia: Lippincott,
Williams and Wilkins; 2005; with permission.)
Fig. 11. Meatoplasty. (A) The normal meatus is limited posteriorly by overhanging cartilage of
the concha (CON). (B) A crescent of this cartilage may be removed to enlarge the natural me-
atus. (From Nadol JB, McKenna MJ. Surgery of the ear and temporal bone. 2nd edition. Phil-
adelphia: Lippincott, Williams and Wilkins; 2005; with permission.)
from the site, while leaving the cholesteatomatous epithelium intact, allows
osseous healing beneath it over the passage of months, and facilitates a sec-
ond-look completion procedure.
Fig. 12. Blunting of the external auditory canal. The space between the manubrium (M) and the
anterior wall of the external auditory canal (EAC) has been filled with fibrous tissue (F).
Fig. 13. Obliteration of the mastoid bowl. (A) In this left ear, a musculoperiosteal flap (MPF)
with an extension of temporalis fascia (TFE) has been elevated, based on the mastoid tip. (B)
This flap is used later to cover bone pate (BP) placed in the exenterated canal wall down mas-
toid bowl. (From Nadol JB, McKenna MJ. Surgery of the ear and temporal bone. 2nd edition.
Philadelphia: Lippincott, Williams and Wilkins; 2005; with permission.)
REVISION MASTOIDECTOMY 739
Summary
Achieving a safe, dry ear over the long term in chronic active otitis media
with or without cholesteatoma often requires revision surgery; initial failure
rates approach 30% of cases in some series. Categorizing and locating the
recurrent disease process, and analyzing the reasons for previous failure,
are necessary to plan a successful revision surgical procedure. It is also nec-
essary to be aware of the various histopathologic correlates of chronic otitis
media, including osteoresorptive and osteosclerotic processes. In addition to
complete removal of disease, modifications to prevent recurrent disease, in-
cluding meatoplasty, canalplasty, graft stiffening procedures, and oblitera-
tive techniques, may be used. Careful attention to detail and analysis of
the reasons for previous surgical failure will lead to a customized, case-spe-
cific plan that may require modification during the course of the procedure,
based on surgical findings.
References
[1] Jepsen O, Swergius E. Cavities after retro-auricular radical ear operations with special ref-
erence to significance of primary factors. Acta Otolaryngol 1951;39:388–94.
[2] Ohrt HH. On recurrence in cavities after radical mastoidectomy with special reference to the
complications which may arise. Acta Otolaryngol (Stockh.) 1957;47:346–52.
[3] Smyth GD. Postoperative cholesteatoma in combined approach tympanoplasty. J Laryngol
Otol 1976;90:597–621.
[4] Sheehy J, Brackmann DE, Graham MD. Cholesteatoma surgery: residual and recurrent dis-
ease. A review of 1,024 cases. Ann Otol 1977;86:451–62.
[5] Palmgren O. Long term results of open cavity and tympanomastoid surgery of the chronic
ear. Acta Otolaryngol 1979;88(5–6):343–9.
[6] Van Baarle PW, Juygen PL, Brinkman WF. Findings in surgery for chronic otitis media.
A retrospective data-analysis of 2225 cases followed for 2 years. Clin Otolaryngol Allied
Sci 1983;8(3):151–8.
[7] Cody DTR, McDonald TJ. Mastoidectomy for acquired cholesteatoma: follow-up to 20
years. Laryngoscope 1984;94:1027–30.
[8] Lau T, Tos M. Long term results of surgery for chronic granulating otitis. Am J Otolaryngol
1986;7(5):341–5.
[9] Pillsbury HC 3rd, Carrasco VN. Revision mastoidectomy. Arch Otolaryngol Head Neck
Surg 1990;116(9):1019–22.
740 NADOL
[10] Vartiainen E, Kansanen M. Tympanomastoidectomy for chronic otitis media without cho-
lesteatoma. Otolaryngol Head Neck Surg 1992;106(3):230–4.
[11] Syms MJ, Luxford WM. Management of cholesteatoma: status of the canal wall. Laryngo-
scope 2003;113(3):443–8.
[12] Kos MI, Castrillon R, Montandon P, et al. Anatomic and functional long term results of ca-
nal wall-down mastoidectomy. Ann Otol Rhinol Laryngol 2004;113(11):872–6.
[13] Merchant SN, Wang P, Jang CH, et al. Efficacy of tympanomastoid surgery for control of
infection in active chronic otitis media. Laryngoscope 1997;107(7):872–7.
[14] Richardson GS. Aditus block. Ann Otol Rhinol Laryngol 1963;72:223–36.
[15] Proctor B. Attic-aditus block and the tympanic diaphragm. Ann Otol Rhinol Laryngol 1971;
80(3):371–5.
[16] Jokippi AM, Karma P, Ojala K, et al. Anaerobic bacteria in chronic otitis media. Arch Oto-
laryngol 1977;103(5):278–80.
[17] Erkan M, Aslan T, Sevuk E, et al. Bacteriology of chronic suppurative otitis media. Ann Otol
Rhinol Laryngol 1994;103:771–4.
[18] Kenna M, Bluestone CD, Reilly JS, et al. Medical management of chronic suppurative otitis
media without cholesteatoma in children. Laryngoscope 1986;96:146–51.
[19] Nadol JB Jr. Causes of failure of mastoidectomy for chronic otitis media. Laryngoscope
1985;95(4):410–3.
[20] Nadol JB Jr, Krouse JH. The hypotympanum and infralabyrinthine cells in chronic otitis
media. Laryngoscope 1991;101:137–41.
[21] Rambo JHJ. The use of musculoplasty: Advantages and disadvantages. Ann Otol 1965;74:
535–54.
[22] Ramsey MJ, Merchant SN, McKenna MJ. Postauricular periosteal-pericranial flap for mas-
toid obliteration and canal wall down tympanomastoidectomy. Otol Neurotol 2004;25(6):
873–8.
[23] Black B. Mastoidectomy elimination: obliterate, reconstruct, or ablate? Am J Otol 1998;
19(5):551–7.
[24] Sheehy JL. Bone pate collecting device. Otolaryngol Head Neck Surg 1980;88(4):472.
[25] Cheney ML, Megerian CA, Brown MT, et al. The use of the temporoparietal fascial flap in
temporal bone reconstruction. Am J Otol 1996;17:137–42.